Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 125-132

  Stern, Mariana C ^a   Gimenez Conti, Irma B ^a   Budunova, Irina ^a   Coghlan, Lezlee ^b   Fischer, Susan M ^a   DiGiovanni, John ^a   Slaga, Thomas J ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CELL CYCLE PROTEIN; CYCLIN D1; CYCLINE; GAP JUNCTION PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PAPILLOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TISSUE TRANSPLANTATION; TUMOR GROWTH; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIGENS, SURFACE; CARCINOGENS; CYCLIN D1; DISEASE SUSCEPTIBILITY; FEMALE; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6BETA4; INTEGRINS; MICE; MICE, INBRED STRAINS; PAPILLOMA; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 0031820169     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.125     Document Type: Article

References (53)

1. Boutwell, R.K. (1964) Some biological aspects of skin carcinogenesis. Prog. in Exp. Tumor Res., 4, 207-250.
2. DiGiovanni, J., Slaga, T.J. and Boutwell, R.K. (1980) Comparison of the tumor initiating activity of 7,12-dymethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CD-1 mice. Carcinogenesis, 1, 381-389.
3. Fischer, S.M., O'Connell, J.F., Conti, C.J., Tacker, K.C., Fries, J.W., Patrick, K.E., Adams, L.M. and Slaga, T.J. (1987) Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis, 8, 421-424.
4. Gimenez-Conti, I.B., Bianchi, A.B., Fishcer, S.M., Reiners, J.J., Conti, C.J. and Slaga, T.J. (1992) Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res., 52, 3442-3435.
5. Hennings, H., Lowry, D.T., Yuspa, S.H., Mock, B. and Potter, M. (1997) New strains of inbred mice with increased susceptibility to induction of papillomas and squamous cell carcinomas. Molec. Carcinogenesis, 20, 143-150.
6. Stern, M.C., Gimenez-Conti, I.B. and Conti, J.C. (1995) Genetic susceptibility to papilloma progression in the SENCAR mice. Carcinogenesis, 16, 1947-1953.
7. Stern, M.C. and Conti, C.J. (1996) Genetic susceptibility to tumor progression in mouse skin carcinogenesis. Prog. Clin. Biol. Res., 395, 47-55.
8. Gimenez-Conti, I.B., Aldaz, C.M., Bianchi, A.B., Roop, D.R., Slaga, T.J. and Conti, C.J. (1990) Early expression of type I K13 keratin in the progression of mouse skin papillomas. Carcinogenesis, 11, 1995-1999.
9. Tennembaum, T., Weiner, A.K., Belanger, M.A.J., Glick, A.B., Hennings, H. and Yuspa, S.H. (1993) The suprabasal expression of α6β4 integrin is associated with a hish risk for malignant progression in mouse skin carcinogenesis. Cancer Res., 53, 4803-4810.
10. Budunova, I.V., Carbajal, S. and Slaga, T.J. (1995) The expression of gap junctional proteins during different stages of mouse skin carcinogenesis. Carcinogenesis, 16, 2717-2724.
11. Budunova, I.V., Carbajal, S., Viaje, A. and Slaga, T.J. (1996) Connexin expression in epidermal cell lines from SENCAR mouse skin tumors. Molec. Carcinogenesis, 15, 190-201.
12. Kamibayashi, Y., Oyamda, Y., Mori, M. and Oyamada, M. (1995) Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis, 16, 1287-1297.
13. Rho, O., Beltran, L., Gimenez-Conti, I.B. and DiGiovanni, J. (1994) Altered expression of the epidermal growth factor receptor and transforming growth factor-α during, multistage skin carcinogenesis in SENCAR mice. Molec. Carcinogenesis, 11, 19-28.
14. Patalamai, B., Burow, D.L., Gimenez-Conti, I.B., Zenklusen, J.C., Conti, C.J., Klein-Szanto, A.J.P. and Fischer, S.M. (1994) Altered expression of transforming growth factor-β1 mRNA and protein in mouse skin carcinogenesis. Mol. Carcinogenesis, 9, 220-229.
15. Robles, A.I. and Conti, C.J. (1995) Early over-expression of cyclin D1 in mouse skin carcinogenesis. Carcinogenesis, 16, 781-786.
16. Tennembaum, T., Yuspa, S.H., Grover, A., Castronoveo, V., Sobel, M.E., Yamada, Y. and De Luca, L.M. (1992) Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor promotion. Cancer Res., 52, 2966-2967.
17. Keyomarsi, K. and Pardee, A.B. (1993) Redundant cyclin over-expression and gene amplification in breast cancer cells. Proc. Natl Acad. Sci. USA, 90, 1112-1116.
18. Lammie, G.A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A. and Peters, G. (1991) D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene, 6, 439-444.
19. Jiang, W., Kahn, S.M., Tomita, N., Zhang, Y.J., Lu, S.H. and Weinstein, I.B. (1992) Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52, 2980-2983.
20. Leach, F.S., Elledge, S.J., Sherr, C.J., Willson, J.K.V., Markowitz, S., Kinzler, K.W. and Vogelstein, B. (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53, 1986-1989.
21. Zhang, Y.J., Cjiang, W., Chen, J.C., Lee, C.S., Kahn, S.M., Santella, R.M. and Weinstein, I.B. (1993) Amplification and over-expression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun., 196, 1010-1016.
22. Bianchi, A.B., Fischer, S.M., Robles, A.I., Rinchik, E.M. and Conti, C.J. (1993) Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene, 8, 1127-1133.
23. Filmus, J., Robles, A.I., Shi, W., Wong, M.J., Colombo, L.L. and Conti, C.J. (1994) Induction of cyclin D1 over-expression by activated ras. Oncogene, 9, 3627-3633.
24. Winston, J.T., Coats, S.R., Wang, Y.Z. and Pledger, W.J. (1996) Regulation of the cell cycle machinery by oncogenic ras. Oncogene, 12, 127-134.
25. Arber, N., Sutter, T., Miyake, M., Kahn, S.M., Venkatraj, V.S., Sobrino, A., Warburton, D., Holt, P.R. and Weinstein, I.B. (1996) Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene, 12, 1903-1908.
26. Aldaz, C.M., Trono, D., Larcher, F., Slaga, T.J. and Conti, C.J. (1989) Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Molec. Carcinogenesis, 2, 22-26.
27. Linardopoulos, S., Street, A.J., Quelle, D.E., Parry, D., Peters, G., Sherr, C.J. and Balmain, A. (1995) Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res., 55, 5168-5172.
28. Stern, M.C., Duran, H.A., McKenna, E.A.E. and Conti, C.J. (1997) Increased apoptosis during papilloma development in mice susceptible to tumor progression. Molec. Carcinogenesis, 20, 137-142.
29. Glick, A.B., Kulkarni, A.B., Tennembaum, T., Hennings, H., Flanders, K.C., O'Reilly, M., Sporn, M.B., Karlsson, S. and Yuspa, S.H. (1993) Loss of expression of transforming growth factor β in skin and skin tumors is associated with hypreproliferation and high risk for malignant conversion. Proc. Natl Acad. Sci. USA, 90, 6076-6080.
30. Rundhaug, J.E., Gimenez-Conti, I.B., Stern, M.C., et al. (1997) Changes in protein expression during multistage mouse skin carcinogenesis. Molec. Carcinogenesis, 20, 125-136.
31. Flanders, K.C., Thompson, N.L., Cissel, D.S., Van Obberghen-Schillong, E., Baker, C.C., Kass, M.E., Ellingsworth, L.R., Roberts, A.B. and Sporn, M.B. (1989) Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J. Cell Biol., 108, 653-660.
32. Arteaga, C.L., Coffey, R.J., Jr, Dugger, T.C., McCutchen, C.M., Moses, H.L. and Lyons, R.M. (1990) Growth stimulation of human breast cancer cells with anti-transformnig growth factor β antibodies: evidence for negative autocrine regulation by transforming growth factor β. Cell Growth Differ., 1, 367-374.
33. Wu, S.P., Theodoresou, D., Kerbel, R.S., Willson, J.K., Mulder, K.M., Humphrey, L.E. and Brattain, M.G. (1992) TGF-β1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol., 116, 187-196.
34. Wu, S.P., Sun, L., Willson, J.K.V., Humphrey, L., Kerbel, K. and Brattain, M.G. (1993) Repression of autocrine transforming growth factor β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ., 4, 115-123.
35. null mice is prognostic for a high risk of malignant conversion. Cancer Res., 54, 5831-5836.
36. Sun, L., Wu, G., Willson, J.K.V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L.E., Wang, X. and Brittain, M.G. (1994) Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-1 cells. J. Biol. Chem., 269, 42, 26449-26455.
37. Glick, A.B., Lee, M.M., Darwiche, N., Kulkarni, A.B., Karlsson, S. and Yuspa, S.H. (1994) Targeted deletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes Dev., 8, 2429-2440.
38. Welch, D.R., Fabra, A. and Nakajima, M. (1990) Transforming growth factor β1 stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl Acad. Sci. USA, 87, 7678-7682.
39. Torre-Amione, G., Beauchamp, R.D., Koeppen, H., Park, B.H., Schreiber, H., Moses, H.L. and Rowley, D.A. (1990) A highly immunogenic tumor transfected with a murine transforming growth factor type β-1 cDNA escapes immuno surveillance. Proc. Natl Acad. Sci. USA, 87, 1486-1490.
40. Arrick, B.A., Lopez, A.R., Elfman, F., Ebner, R., Damsky, C.H. and Derynck, R. (1992) Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J. Cell Biol., 118, 715-726.
41. Steiner, M.S. and Barrrack, E.R. (1992) Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 6, 15-25.
42. Chang, H.L., Gillet, N., Figaro, I., Lopez, A.R., Palladino, M.A. and Derynck, R. (1993) Increased transforming grwoth factor β expression inhibits cell proliferation in vitro yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res., 53, 4391-4398.
43. Cui, W., Fowlis, D.J., Bryson, S., Duffie, E., Ireland, H., Balmain, A. and Akhurst, R.J. (1996) TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86, 531-542.
44. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H. and Reichmann, E. (1996) TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Develop., 10, 2462-2477.
45. Caulin, C., Scholl, F.G., Frontelo, P., Gamallo, C. and Quintanilla, M. (1995) Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-β1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ., 6, 1027-1035.
46. Okamoto, A., Jiang, W., Kim, S.-J., Spillare, E.A., Stoner, G.D., Weinstein, I.B. and Harris, C.C. (1994) Overexpression of human cyclin D1 reduces the transforming growth factor β (TGF-β) type II receptor and growth inhibition by TGF-β1 in an inmortalized human esophageal epithelial cell line. Proc. Natl Acad. Sci. USA, 91, 11576-11580.
47. Yamasaki, H. (1990) Gap junctional intercellular communication and carcinogenesis. Carcinogenesis, 11, 1051-1058.
48. Holder, J.W., Elmore, E. and Barrett, J.C. (1993) Gap junction function and cancer. Cancer Res., 53, 3475-3485.
49. Klaunig, J.E. and Ruch, R.J. (1990) Role of inhibition of intercellular communication in carcinogenesis. Lab. Invest., 62, 135-146.
50. Tennembaum, T., Belanger, A.J., Glick, A.B., Tamura, R., Quaranta, V. and Yuspa, S.H. (1995) A splice variant of α6 integrin is associated with malignant conversion in mouse skin carcinogenesis. Proc. Natl Acad. Sci. USA, 92, 7041-7045.
51. Di Giovanni, J., Walker, S.E., Aldaz, C.M., Slaga, T.J. and Conti, C.J. (1993) Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice. Carcinogenesis, 14, 1831-1836.
52. Hennings, H., Shores, R., Wenk, M.L., Spangler, E.F., Tarone, R. and Yuspa, S.H. (1983) Malignant conversion of mouse skin tumors is increased by tumour initiators and unaffected by tumour promoters. Nature, 304, 67-69.
53. Hennings, H., Shores, R., Mitchell, P., Spangler, E.F. and Yuspa, S.H. (1985) Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis, 6, 1607-1610.